EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Palliative care for in-patient malignant glioma patients in Germany

Palliativversorgung bei stationären Patient:innen mit malignem Gliom in Deutschland

Larissa Fink, Birgitt van Oorschot, Christiane von Saß, Maxine Dibué, Marie-Therese Foster, Heidrun Golla, Ronald Goldbrunner, Christian Senft, Aaron Lawson McLean, Martin Hellmich, Nazife Dinc, Raymond Voltz und 3 weitere

Journal of Neuro-Oncology · 2024-04 · 167 (2) · 323-338

DOI: 10.1007/s11060-024-04611-8 ↗

Auf einen Blick

Eine retrospektive Querschnittsanalyse untersuchte die Palliativversorgung von Patient:innen mit malignem Gliom in Deutschland von 2019 bis 2022. Nur ein kleiner Teil erhielt komplexe oder spezialisierte palliative medizinische Versorgung.

Fragestellung

Wie häufig wurden stationäre Patient:innen mit malignem Gliom in Deutschland von 2019 bis 2022 palliativ versorgt?

Methode

Retrospektive Querschnittsstudie mit Daten des InEK für 2019 bis 2022; eingeschlossen wurden Patient:innen mit primärer oder sekundärer C71-Diagnose.

Ergebnisse

101.192 Krankenhausfälle. 6.129 (6 %) endeten stationär, 2.798 (2,8 %) führten in ein Hospiz. 10.592 Fälle (10,5 %) erhielten komplexe oder spezialisierte palliative medizinische Versorgung.

Schlussfolgerung der Autor:innen

Trotz schlechter Prognose erhielten nur wenige Patient:innen mit malignem Gliom fortgeschrittene Palliativversorgung; etwa 10 % der stationären Fälle und etwa 40 % der im Krankenhaus Verstorbenen.

Kernaussagen

  • Nur 10,5 % erhielten komplexe oder spezialisierte Palliativversorgung
  • Bei Krankenhausversterben erhielten 40,4 % palliative Versorgung
  • Niedrigere Raten bei unter 65-Jährigen und bei Männern

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 20.03.2024. Verfasst von Larissa Fink und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Palliative and Neuro-palliative Care, Brandenburg Medical School Theodor Fontane, Faculty of Health Sciences Brandenburg, Am Seebad 82/83,…. Hauptthemen laut MEDLINE: Palliative Care, Glioma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Hochschule Brandenburg CAMPUS gGmbH.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Malignant gliomas impose a significant symptomatic burden on patients and their families. Current guidelines recommend palliative care for patients with advanced tumors within eight weeks of diagnosis, emphasizing early integration for malignant glioma cases. However, the utilization rate of palliative care for these patients in Germany remains unquantified. This study investigates the proportion of malignant glioma patients who either died in a hospital or were transferred to hospice care from 2019 to 2022, and the prevalence of in-patient specialized palliative care interventions.

Methods

In this cross-sectional, retrospective study, we analyzed data from the Institute for the Hospital Remuneration System (InEK GmbH, Siegburg, Germany), covering 2019 to 2022. We included patients with a primary or secondary diagnosis of C71 (malignant glioma) in our analysis. To refine our dataset, we identified cases with dual-coded primary and secondary diagnoses and excluded these to avoid duplication in our final tally. The data extraction process involved detailed scrutiny of hospital records to ascertain the frequency of hospital deaths, hospice transfers, and the provision of complex or specialized palliative care for patients with C71-coded diagnoses. Descriptive statistics and inferential analyses were employed to evaluate the trends and significance of the findings.

Results

From 2019 to 2022, of the 101,192 hospital cases involving malignant glioma patients, 6,129 (6% of all cases) resulted in in-hospital mortality, while 2,798 (2.8%) led to hospice transfers. Among these, 10,592 cases (10.5% of total) involved the administration of complex or specialized palliative medical care. This provision rate remained unchanged throughout the COVID-19 pandemic. Notably, significantly lower frequencies of complex or specialized palliative care implementation were observed in patients below 65 years ( p < 0.0001) and in male patients (p adjusted = 0.016). In cases of in-hospital mortality due to malignant gliomas, 2,479 out of 6,129 cases (40.4%) received specialized palliative care.

Conclusion

Despite the poor prognosis and complex symptomatology associated with malignant gliomas, only a small proportion of affected patients received advanced palliative care. Specifically, only about 10% of hospitalized patients with malignant gliomas, and approximately 40% of those who succumb to the disease in hospital settings, were afforded complex or specialized palliative care. This discrepancy underscores an urgent need to expand palliative care access for this patient demographic. Additionally, it highlights the importance of further research to identify and address the barriers preventing wider implementation of palliative care in this context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palliative CareGliomaHumansMaleRetrospective StudiesCross-Sectional StudiesPandemics

Stichwörter der Autor:innen

Early integrationGlioblastomaMalignant gliomaNeuropalliative carePalliative carePredictive factors

Autor:innen und Institutionen

  • Center for Palliative and Neuro-palliative Care, Brandenburg Medical School Theodor Fontane, Faculty of Health Sciences Brandenburg, Am Seebad 82/83, 15562, Rüdersdorf bei Berlin, Germany.
  • Interdisciplinary Center for Palliative Medicine, University Hospital Würzburg, Würzburg, , Germany.
  • Center for Neurosurgery, Department of General Neurosurgery, University of Cologne, Cologne, Germany.
  • Department of Neurosurgery, Goethe University Hospital, Frankfurt am Main, Germany.
  • Department of Palliative Medicine, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
  • Center of Neuro-Oncology, Department of Neurosurgery, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.

Förderung

  • Medizinische Hochschule Brandenburg CAMPUS gGmbH

Zitieren

APA

Fink, L., van Oorschot, B., von Saß, C., Dibué, M., Foster, M. T., Golla, H., Goldbrunner, R., Senft, C., Lawson McLean, A., Hellmich, M., Dinc, N., Voltz, R., Melching, H., Jungk, C., & Kamp, M. A. (2024). Palliative care for in-patient malignant glioma patients in Germany. Journal of Neuro-Oncology, 167(2), 323-338. https://doi.org/10.1007/s11060-024-04611-8

Vancouver

Fink L, van Oorschot B, von Saß C, Dibué M, Foster MT, Golla H, et al. Palliative care for in-patient malignant glioma patients in Germany. Journal of Neuro-Oncology. 2024;167(2):323-338. doi:10.1007/s11060-024-04611-8

BibTeX
@article{Fink2024,
  author = {Fink, Larissa and van Oorschot, Birgitt and von Saß, Christiane and Dibué, Maxine and Foster, Marie-Therese and Golla, Heidrun and Goldbrunner, Ronald and Senft, Christian and Lawson McLean, Aaron and Hellmich, Martin and Dinc, Nazife and Voltz, Raymond and Melching, Heiner and Jungk, Christine and Kamp, Marcel A},
  title = {Palliative care for in-patient malignant glioma patients in Germany},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  volume = {167},
  number = {2},
  pages = {323--338},
  doi = {10.1007/s11060-024-04611-8}
}
Kostenlos starten →